• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤与免疫细胞中的过氧化物酶体增殖物激活受体γ:对疾病发病机制及治疗意义的见解

PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications.

作者信息

Sobolev Vladimir, Tchepourina Ekaterina, Soboleva Anna, Denisova Elena, Korsunskaya Irina, Mezentsev Alexandre

机构信息

Laboratory of Physicochemical and Genetic Problems in Dermatology, Center for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow 109029, Russia.

Moscow Center of Dermatovenerology and Cosmetology, Moscow 119071, Russia.

出版信息

Cells. 2025 Apr 2;14(7):534. doi: 10.3390/cells14070534.

DOI:10.3390/cells14070534
PMID:40214488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11989151/
Abstract

Changes in skin pigmentation, like hyperpigmentation or moles, can affect appearance and social life. Unlike locally containable moles, malignant melanomas are aggressive and can spread rapidly, disproportionately affecting younger individuals with a high potential for metastasis. Research has shown that the peroxisome proliferator-activated receptor gamma (PPAR-γ) and its ligands exhibit protective effects against melanoma. As a transcription factor, PPAR-γ is crucial in functions like fatty acid storage and glucose metabolism. Activation of PPAR-γ promotes lipid uptake and enhances sensitivity to insulin. In many cases, it also inhibits the growth of cancer cell lines, like breast, gastric, lung, and prostate cancer. In melanoma, PPAR-γ regulates cell proliferation, differentiation, apoptosis, and survival. During tumorigenesis, it controls metabolic changes and the immunogenicity of stromal cells. PPAR-γ agonists can target hypoxia-induced angiogenesis in tumor therapy, but their effects on tumors can be suppressive or promotional, depending on the tumor environment. Published data show that PPAR-γ-targeting agents can be effective in specific groups of patients, but further studies are needed to understand lesser-known biological effects of PPAR-γ and address the existing safety concerns. This review provides a summary of the current understanding of PPAR-γ and its involvement in melanoma.

摘要

皮肤色素沉着的变化,如色素沉着过度或痣,会影响外观和社交生活。与局部可控的痣不同,恶性黑色素瘤具有侵袭性,可迅速扩散,对具有高转移潜力的年轻个体影响尤为严重。研究表明,过氧化物酶体增殖物激活受体γ(PPAR-γ)及其配体对黑色素瘤具有保护作用。作为一种转录因子,PPAR-γ在脂肪酸储存和葡萄糖代谢等功能中起关键作用。PPAR-γ的激活促进脂质摄取并增强对胰岛素的敏感性。在许多情况下,它还能抑制乳腺癌、胃癌、肺癌和前列腺癌等癌细胞系的生长。在黑色素瘤中,PPAR-γ调节细胞增殖、分化、凋亡和存活。在肿瘤发生过程中,它控制代谢变化和基质细胞的免疫原性。PPAR-γ激动剂可在肿瘤治疗中靶向缺氧诱导的血管生成,但其对肿瘤的影响可能是抑制性的或促进性的,这取决于肿瘤环境。已发表的数据表明,靶向PPAR-γ的药物在特定患者群体中可能有效,但需要进一步研究以了解PPAR-γ鲜为人知的生物学效应并解决现有的安全问题。本综述总结了目前对PPAR-γ及其在黑色素瘤中的作用的理解。

相似文献

1
PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications.黑色素瘤与免疫细胞中的过氧化物酶体增殖物激活受体γ:对疾病发病机制及治疗意义的见解
Cells. 2025 Apr 2;14(7):534. doi: 10.3390/cells14070534.
2
PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.过氧化物酶体增殖物激活受体γ调节小眼畸形相关转录因子和β-连环蛋白的表达,并促进小鼠黑色素瘤S91细胞的分化表型。
Pigment Cell Melanoma Res. 2008 Jun;21(3):388-96. doi: 10.1111/j.1755-148X.2008.00460.x. Epub 2008 Apr 26.
3
The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells.转录因子 PPAR-γ 在银屑病发病机制中的作用,涉及皮肤细胞和免疫细胞。
Int J Mol Sci. 2022 Aug 26;23(17):9708. doi: 10.3390/ijms23179708.
4
Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.过氧化物酶体增殖物激活受体-γ 激活通过拮抗 Smad3 介导的上皮-间充质转化抑制肿瘤转移。
Mol Cancer Ther. 2010 Dec;9(12):3221-32. doi: 10.1158/1535-7163.MCT-10-0570.
5
Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: promising new therapeutic targets?过氧化物酶体增殖物激活受体 (PPAR) 和维生素 D 受体 (VDR) 在黑素瘤细胞中的信号通路:有前途的新治疗靶点?
J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):383-6. doi: 10.1016/j.jsbmb.2010.03.003. Epub 2010 Mar 7.
6
Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias.过氧化物酶体增殖物激活受体γ和视黄酸X受体配体是白血病分化和凋亡的有效诱导剂。
Mol Cancer Ther. 2004 Oct;3(10):1249-62.
7
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.过氧化物酶体增殖物激活受体γ激活对卵巢癌细胞的细胞和分子影响。
Neoplasia. 2006 Oct;8(10):851-61. doi: 10.1593/neo.06433.
8
M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.肿瘤相关巨噬细胞的 M2/M1 比值与具有 1 类和 2 类分子特征的葡萄膜黑色素瘤中 PPAR-γ 的表达。
Exp Eye Res. 2013 Feb;107:52-8. doi: 10.1016/j.exer.2012.11.012. Epub 2012 Nov 30.
9
Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro.过氧化物酶体增殖物激活受体γ激动剂对人恶性黑色素瘤细胞的体外抗增殖作用。
Anticancer Drugs. 2006 Mar;17(3):325-32. doi: 10.1097/00001813-200603000-00011.
10
Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).过氧化物酶体增殖物激活受体γ(PPARγ)通过逆转转移性非小细胞肺癌(NSCLC)细胞的未分化表型来抑制肿瘤发生。
Oncogene. 2005 Feb 17;24(8):1412-22. doi: 10.1038/sj.onc.1208333.

本文引用的文献

1
Association between pioglitazone use and bladder cancer: A systematic review.吡格列酮使用与膀胱癌之间的关联:一项系统综述。
Bladder (San Franc). 2024 Dec 17;11(4):e21200023. doi: 10.14440/bladder.2024.0039. eCollection 2024.
2
Benign Nevi Mimicking Melanoma: A Diagnostic Dilemma.酷似黑色素瘤的良性痣:诊断难题
Cureus. 2024 Nov 30;16(11):e74821. doi: 10.7759/cureus.74821. eCollection 2024 Nov.
3
Metabolic Reprogramming of Cancer-Associated Fibroblast in the Tumor Microenvironment: From Basics to Clinic.肿瘤微环境中癌症相关成纤维细胞的代谢重编程:从基础到临床
Clin Med Insights Oncol. 2024 Oct 21;18:11795549241287058. doi: 10.1177/11795549241287058. eCollection 2024.
4
Regulation of CD8+ T cells by lipid metabolism in cancer progression.脂质代谢在癌症进展中对 CD8+ T 细胞的调控。
Cell Mol Immunol. 2024 Nov;21(11):1215-1230. doi: 10.1038/s41423-024-01224-z. Epub 2024 Oct 14.
5
Reassessment of pioglitazone and bladder cancer based on FAERS database.基于FAERS数据库对吡格列酮与膀胱癌的重新评估。
Expert Opin Drug Saf. 2024 Sep 20:1-8. doi: 10.1080/14740338.2024.2390000.
6
Prevention and Treatment of Skin Pigmentation Disorders.皮肤色素沉着紊乱的预防与治疗。
J Clin Med. 2024 Jul 24;13(15):4312. doi: 10.3390/jcm13154312.
7
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling.恶性黑色素瘤:概述、新观点及维生素D信号传导
Cancers (Basel). 2024 Jun 18;16(12):2262. doi: 10.3390/cancers16122262.
8
New Insights into the Role of PPARγ in Skin Physiopathology.PPARγ 在皮肤生理病理中的作用新见解。
Biomolecules. 2024 Jun 19;14(6):728. doi: 10.3390/biom14060728.
9
Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth.过氧化物酶体增殖物激活受体:肿瘤进展和生长的关键调节因子。
Transl Oncol. 2024 Sep;47:102039. doi: 10.1016/j.tranon.2024.102039. Epub 2024 Jun 24.
10
Nevi and Melanoma.痣和黑素瘤。
Hematol Oncol Clin North Am. 2024 Oct;38(5):939-952. doi: 10.1016/j.hoc.2024.05.005. Epub 2024 Jun 15.